Albemarle Completes Sale of Controlling Stake in Ketjen to KPS Capital Partners (Form 8-K)

Albemarle Completes Sale of Controlling Stake in Ketjen to KPS Capital Partners

CHARLOTTE, N.C., March 2, 2026 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity, and health, today announced it has completed the sale of a controlling stake in Ketjen Corporation's refining catalyst solutions business (Ketjen) to affiliates of KPS Capital Partners, LP (KPS).

Albemarle retains a minority stake in Ketjen, with KPS having a majority of the Board of Directors and operational control. Albemarle retains 100% ownership of Ketjen's Performance Catalyst Solutions business, which has been integrated into Albemarle's product portfolio.

Combined with the sale of its 50% interest in the Eurecat joint venture to Axens SA, which was completed in January 2026, Albemarle has received a combined $670 million in pre-tax proceeds between the two transactions. Albemarle expects to use the proceeds for debt reduction and other general corporate purposes.

"Our continued investment in Ketjen alongside KPS demonstrates our confidence in the company's growth and value-creation potential," said Kent Masters, Chairman and CEO of Albemarle. "We are committed to supporting Ketjen's next chapter while strengthening Albemarle's portfolio focus and financial flexibility."

Goldman Sachs & Co. LLC acted as exclusive financial advisor, and K&L Gates LLP served as legal advisor to Albemarle for the transaction.

About Albemarle
Albemarle Corporation (NYSE: ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.

Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.

About KPS Capital Partners

KPS, through its affiliated management entities, is the manager of the KPS Special Situations Funds, a family of investment funds with approximately $19.5 billion of assets under management (as of September 30, 2025). For over three decades, the Partners of KPS have worked exclusively to realize significant capital appreciation by making controlling equity investments in manufacturing and industrial companies across a diverse array of industries, including basic materials, branded consumer, healthcare and luxury products, automotive parts, capital equipment and general manufacturing. KPS creates value for its investors by working constructively with talented management teams to make businesses better, and generates investment returns by structurally improving the strategic position, competitiveness and profitability of its portfolio companies, rather than primarily relying on financial leverage. The KPS Funds' portfolio companies currently generate aggregate annual revenues of approximately $21.2 billion, operate 202 manufacturing facilities in 21 countries, and have approximately 55,000 employees, directly and through joint ventures

worldwide (as of September 30, 2025). The KPS investment strategy and portfolio companies are described in detail at www.kpsfund.com.